menu
    • menu

    Company profile for Myovant Sciences

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are committed to addressing unmet need in women’s health and prostate cancer through purpose-driven science, empowering medicines, and transformative advocacy. Our purpose is resolute and fueled by the opportunity to improve the lives of millions of patients, many impacted by diseases during their most productive years of life. Despite the significant burden of these diseases, patients do not have the options they dese...
    We are committed to addressing unmet need in women’s health and prostate cancer through purpose-driven science, empowering medicines, and transformative advocacy. Our purpose is resolute and fueled by the opportunity to improve the lives of millions of patients, many impacted by diseases during their most productive years of life. Despite the significant burden of these diseases, patients do not have the options they deserve and need.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Myovant SciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2000 Sierra Point Parkway, 9th Floor Brisbane, CA 94005
    Telephone
    Telephone
    650-392-0222
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.myovant.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/myovant-sciences/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/myovant?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Myovant endometriosis survey shows crippling effect on women
    Myovant endometriosis survey shows crippling effect on women

    19 May 2023

    // Jacqueline Renfrow FIERCE PHARMA

    https://www.fiercepharma.com/marketing/myovant-endometriosis-survey-shows-women-consider-quitting-work-school-due-symptoms

    Jacqueline Renfrow FIERCE PHARMA
    19 May 2023
    Share Share
    Sumitomo Pharma tidies up 7 units into 1 combined U.S. entity
    Sumitomo Pharma tidies up 7 units into 1 combined U.S. entity

    03 Apr 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/sumitomo-pharma-tidies-7-units-one-combined-us-entity-spring-cleaning

    Annalee Armstrong FIERCE BIOTECH
    03 Apr 2023
    Share Share
    Sumitovant Biopharma Acquires Myovant Sciences in $1.7B Deal
    Sumitovant Biopharma Acquires Myovant Sciences in $1.7B Deal

    10 Mar 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-03-10/sumitovant-biopharma-acquires-myovant-sciences-in-17b-deal/?widget=listSection

    CONTRACT PHARMA
    10 Mar 2023
    Share Share
    Myovant Announces Updates and Financial Results for Third Fiscal Quarter 2022
    Myovant Announces Updates and Financial Results for Third Fiscal Quarter 2022

    26 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/26/2596463/0/en/Myovant-Sciences-Announces-Corporate-Updates-and-Financial-Results-for-Third-Fiscal-Quarter-2022.html

    GLOBENEWSWIRE
    26 Jan 2023
    Share Share
    Myovant Sciences Investor Alert by the Former Attorney General of Louisiana
    Myovant Sciences Investor Alert by the Former Attorney General of Louisiana

    25 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230125005713/en

    BUSINESSWIRE
    25 Jan 2023
    Share Share
    Myovant, Pfizer debut first branded campaign for prostate cancer med Orgovyx
    Myovant, Pfizer debut first branded campaign for prostate cancer med Orgovyx

    13 Jan 2023

    // Beth Snyder Bulik ENDPTS

    https://endpts.com/myovant-pfizer-debut-first-branded-campaign-for-prostate-cancer-med-orgovyx/

    Beth Snyder Bulik ENDPTS
    13 Jan 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search